By Cole Petrochko, Staff Writer, MedPage Today
Published: August 13, 2009
WASHINGTON -- The FDA has issued two final rules expanding access to investigational drugs for seriously ill patients who have no alternatives and regulating drug developers' charges for those medicines.
No comments:
Post a Comment